Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Drug delivery balloon catheter

A balloon catheter and balloon technology, applied in the field of drug-eluting balloons, can solve the problems of uncontrollable, unpredictable, insufficient drug amount, etc.

Active Publication Date: 2020-08-04
VASCUROS MEDICAL SHANGHAI CO LTD
View PDF6 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0014] (2) There are insufficient, uncontrollable and unpredictable problems in the drug release, transfer and absorption process
But it also increases the cost and time required to perform the procedure
[0016] (4) In addition, before the drug reaches the treated lesion, a large amount of uncontrollable drug loss may cause drug-coated particles or even drug fragments
And a large number of drug-coated particles or debris may break off the balloon surface and enter the patient's bloodstream

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Drug delivery balloon catheter
  • Drug delivery balloon catheter
  • Drug delivery balloon catheter

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0264] Transport loss / travel loss

[0265] Use the same drug coating formula and coating method to coat the test object.

[0266] Test object

[0267] Device A employs a Figure 6b Similar drug delivery systems, the distal end of the outer cannula is as follows Figure 11b The external expansion shown.

[0268] The drug delivery device of device B is a common balloon catheter (DEB) without an outer sheath.

[0269] experimental method

[0270] The in vitro test method was adapted from Seidlitz et al. In Vitro Assay of Drug Transfer from Drug-Coated Balloons (2013), PLoS ONE8(12):e83992 (doi:10.1371 / journal.pone.0083992).

[0271] The following adjustments were made:

[0272] ·Silicone tube is used to simulate the blood vessel wall.

[0273] • The simulated vessel wall was not imaged, therefore the balloon was not fluorescently treated.

[0274] • The drug components were extracted from acetonitrile and analyzed at 227nm using a UV spectrometer.

[0275] • The balloon ...

experiment example 2

[0281] sheath loss

[0282] Use the same drug coating formula and coating method to coat the test object.

[0283] Test object

[0284] Device C employs a Figure 6b Similar drug delivery systems, the distal end of the outer cannula is as follows Figure 11a straight as shown.

[0285] Device D employs a Figure 6b Similar drug delivery systems, the distal end of the outer cannula is as follows Figure 11b The external expansion shown.

[0286] experimental method

[0287] The in vitro test method was adapted from Seidlitz et al. In Vitro Assay of Drug Transfer from Drug-Coated Balloons (2013), PLoS ONE8(12):e83992 (doi:10.1371 / journal.pone.0083992).

[0288] The following changes were made:

[0289] ·Silicone tube is used to simulate the blood vessel wall.

[0290] • The simulated vessel wall was not imaged, therefore the balloon was not fluorescently treated.

[0291] • The drug components were extracted from acetonitrile and analyzed at 227nm using a UV spectromet...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The current invention relates to the provision of drug eluting balloons and balloon catheters, where the drug coating is protected by a sheath.

Description

technical field [0001] The present invention relates to various drug-eluting balloons that can be inserted into human body lumens and can deposit drug components on treatment sites. [0002] technical background [0003] The listing or discussion of a published document in this specification should not be taken as an acknowledgment that said document is part of the state of the art or is common general knowledge. [0004] Coronary artery disease / peripheral artery disease is a common blood circulation disorder in which plaque builds up in the arteries that restrict blood flow to various parts of the body. The current typical treatment methods are: coronary artery bypass grafting, stent implantation and balloon angioplasty. Months after stenting and balloon angioplasty, some patients develop a narrowing of the vessel wall at the intervention site, called restenosis. The recognition of the problems associated with stenosis and restenosis has led to the development of drug elut...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61M25/10A61M25/01A61L29/08A61L29/16
CPCA61M25/104A61M25/01A61M25/0069A61M25/09A61M25/10A61M2025/105A61M2025/1081A61M2025/0186A61M2025/0039A61M25/0108A61M25/005A61M2025/0062A61M25/0172A61L29/08A61L29/16A61M2025/1063A61M2025/09166A61M2025/0183A61M2025/0047A61L2300/232A61L2300/416A61M25/0097A61M25/0105
Inventor 骆静南王红蕾李博懐
Owner VASCUROS MEDICAL SHANGHAI CO LTD
Features
  • Generate Ideas
  • Intellectual Property
  • Life Sciences
  • Materials
  • Tech Scout
Why Patsnap Eureka
  • Unparalleled Data Quality
  • Higher Quality Content
  • 60% Fewer Hallucinations
Social media
Patsnap Eureka Blog
Learn More